Archives

Paul Liknaitzky hopes for “rigorous research that is neither biased toward panacea thinking, nor ignorant of the best-practice track record and literature to date”. “This field has suffered from [...]

Nigel Strauss and Paul Liknaitzky contend that, at least initially, all training should take place within clinical trials overseen by experienced international clinicians and be limited to [...]

There’s a landmark project underway in Melbourne to find out whether psilocybin – the hallucinogenic compound in magic mushrooms – can be used to improve end-of-life [...]

Psilocybin, the psychoactive compound from magic mushrooms, is being used to treat depression and anxiety in terminally ill patients in a new trial at Melbourne’s St Vincent’s Hospital.